1). An update on the definition of Parkinson’s disease and the syndromic nature of the illness and the need for personalised medicine. 2). The unmet need in treating Parkinson’s disease and the challenges that need to be overcome to make therapeutic progress. 3). A view on future approaches to therapy for motor and non-motor symptoms using dopaminergic and non-dopaminergic approaches.